Cancer News and Research

Latest Cancer News and Research

ProstaCaid dietary supplement supports prostate health

A recent presentation at an international cancer research conference in Greece reviewed the body of data on ProstaCaid, a dietary supplement compound for prostate health. A number of published studies demonstrate the formula's effects in supporting prostate health against specific prostate cancer cell lines and prostate urinary symptoms.

5 Nov 2014

UT Arlington professor uses tissue-engineered artificial lymph nodes to draw prostate cancer cells

A UT Arlington bioengineering professor is using tissue-engineered artificial lymph nodes to attract prostate cancer cells to better target and eradicate the disease.

5 Nov 2014

Light-activated diabetes drug: an interview with Dr David Hodson

We've known about chemicals that can be light-activated for about five to ten years now. They’ve mainly all been applied to neurons and, more specifically, the retina. Nobody has ever really looked at any tissues outside of the nervous system.

5 Nov 2014

New studies offer hope for breast cancer survivors struggling with cancer-related pain, swelling

Two new studies from the Abramson Cancer Center and the Perelman School of Medicine at the University of Pennsylvania offer hope for breast cancer survivors struggling with cancer-related pain and swelling, and point to ways to enhance muscular strength and body image.

5 Nov 2014

New device facilitates diagnosis of prostate cancer

Distinguishing between benign and malignant prostate tissue is difficult. A new device facilitates the diagnosis for doctors: Through a visual analysis, they can reliably determine if they are dealing with carcinoma within a minute-and-a-half. Fraunhofer researchers will be presenting the prototype at the COMPAMED trade fair in Düsseldorf from November 12th to 14th.

5 Nov 2014

Modern bariatric surgery can cut medications in obesity patients

Patients with obesity take significantly fewer medications after weight-loss surgery than their non-surgical counterparts, and end up spending 22.4 percent less on drugs for diabetes and heart disease after four years, according to new research.

5 Nov 2014

Bluebeards Original joins with Lung Cancer Alliance to raise awareness about lung cancer

Bluebeards Original is pleased to announce that it has joined with the Lung Cancer Alliance in the month of November to help raise awareness about lung cancer and lung cancer screening. Throughout the month of November, Bluebeards Original will donate 5% of every purchase made on bluebeardsoriginal.com, while promoting lung cancer awareness on its site and through social media.

5 Nov 2014

More and more elderly people are happy to accept new foods, reveals AZTI study

Elderly people are regarded as traditional consumers, but the AZTI study reveals that there are more and more elderly people who are happy to accept new foods. However, these consumers insist that the new proposals should be similar to or evoke traditional products and flavours and, at the same time, be health-enhancing, have the right nutrient profile for their age, and be flavoursome.

5 Nov 2014

CARLINA, GenBiotech to jointly develop prolonged-release protein formulation for cartilage repair

CARLINA Technologies, a biotechnology company specialized in the development of nanomedicines, today announces the signing of a collaborative agreement with GenBiotech for the development of a prolonged-release pharmaceutical form of a protein. The resultant protein will be used in bone and cartilage repair. Financial details were not disclosed.

5 Nov 2014

Clinical study data of Advaxis' Lm-LLO immunotherapies to be presented at SITC Annual Meeting

Advaxis, Inc., a cancer immunotherapy company, today announced the abstracts of three preclinical and clinical studies highlighting the survival outcomes and anti-tumor effects of its proprietary Lm-LLO cancer immunotherapy technology at the Society for Immunotherapy of Cancer (SITC) 29th Annual Meeting, November 6-9, 2014 at the Gaylord National Hotel and Convention Center in National Harbor, Maryland.

5 Nov 2014

Bowel Cancer UK emphasizes issues relating to diagnostic tests for bowel cancer

Bowel Cancer UK welcomes the comments made by Mike Richards at the National Cancer Research Institute highlighting the lack of access to diagnostic tests for bowel cancer. Bowel Cancer UK has been campaigning on this issue for some time. The latest report from the charity, “Diagnosing bowel cancer early: right test, right time,” highlights their concerns in more detail.

5 Nov 2014

Study suggests possible link between body fat and risk of immunotherapy toxicity

Immunotherapy that can be effective against tumors in young, thin mice can be lethal to obese ones, a new study by UC Davis researchers has found.

4 Nov 2014

Type 2 diabetes and cardiovascular disease share common risk factors

Type 2 diabetes (T2D) and cardiovascular disease (CVD) appear to have a lot in common. They share risk factors such as obesity and they often occur together. If they also share the same genetic underpinings, then doctors could devise a way to treat them together too.

4 Nov 2014

TUSM wins GCE grant for innovative global health and development research project

Temple University School of Medicine announced today that it is a Grand Challenges Explorations winner, an initiative funded by the Bill & Melinda Gates Foundation. Laura Goetzl, MD, MPH, Professor of Obstetrics, Gynecology and Reproductive Sciences; and Vice Chair of Research and Academic Development at Temple University School of Medicine will pursue an innovative global health and development research project, titled "Maternal Blood Biomarkers to Assess Fetal Neurodevelopment."

4 Nov 2014

Study reports IL-37's activity in the adaptive immune system

A University of Colorado Cancer Center study published in this month's Proceedings of the National Academy of Sciences describes the activity of a recently discovered communication molecule of the body's immune system, Interleukin 37 or IL-37. It has been known to limit inflammation and the current study reports its activity in the adaptive immune system: IL-37 inhibits the ability of the immune system to recognize and target new antigens.

4 Nov 2014

Gefitinib drug boosts oesophageal cancer patients' survival by up to six months

Patients with a specific type of oesophageal cancer survived longer when they were given the latest lung cancer drug, according to trial results being presented at the National Cancer Research Institute (NCRI) Cancer Conference today (Wednesday).

4 Nov 2014

Scientists uncover small set of genes critical in aging and neurodegenerative disease

Aging is the most significant and universal risk factor for developing neurodegenerative diseases, such as amyotrophic lateral sclerosis (ALS) and Alzheimer's, Parkinson's and Huntington's diseases. This risk increases disproportionately with age, but no one really knows why.

4 Nov 2014

Study reveals impact of meditation, support groups at cellular level in breast cancer survivors

For the first time, researchers have shown that practising mindfulness meditation or being involved in a support group has a positive physical impact at the cellular level in breast cancer survivors.

4 Nov 2014

People with lactose intolerance at lower risk of suffering from certain cancers

People with lactose intolerance are at lower risk of suffering from lung, breast and ovarian cancers, according to a new study by researchers at Lund University and Region Skåne in Sweden.

4 Nov 2014

VCU Massey Cancer Center researchers develop tool for measuring cancer health literacy

Virginia Commonwealth University (VCU) Massey Cancer Center researchers have developed the first and only tool that can accurately measure cancer health literacy (CHL) and quickly identify patients with limited CHL. This tool has the potential to improve communication and understanding between physicians and patients, which, in turn, could lead to better clinical outcomes.

4 Nov 2014

Cancer News and Research

Latest Cancer News and Research

ProstaCaid dietary supplement supports prostate health

UT Arlington professor uses tissue-engineered artificial lymph nodes to draw prostate cancer cells

Light-activated diabetes drug: an interview with Dr David Hodson

New studies offer hope for breast cancer survivors struggling with cancer-related pain, swelling

New device facilitates diagnosis of prostate cancer

Modern bariatric surgery can cut medications in obesity patients

Bluebeards Original joins with Lung Cancer Alliance to raise awareness about lung cancer

More and more elderly people are happy to accept new foods, reveals AZTI study

CARLINA, GenBiotech to jointly develop prolonged-release protein formulation for cartilage repair

Clinical study data of Advaxis' Lm-LLO immunotherapies to be presented at SITC Annual Meeting

Bowel Cancer UK emphasizes issues relating to diagnostic tests for bowel cancer

Study suggests possible link between body fat and risk of immunotherapy toxicity

Type 2 diabetes and cardiovascular disease share common risk factors

TUSM wins GCE grant for innovative global health and development research project

Study reports IL-37's activity in the adaptive immune system

Gefitinib drug boosts oesophageal cancer patients' survival by up to six months

Scientists uncover small set of genes critical in aging and neurodegenerative disease

Study reveals impact of meditation, support groups at cellular level in breast cancer survivors

People with lactose intolerance at lower risk of suffering from certain cancers

VCU Massey Cancer Center researchers develop tool for measuring cancer health literacy

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Building quality into drug development for safer, faster medicines

How Pulp Fixin Is Turning Paper into High-Performance Sustainable Labware

A new method to measure intracellular water in biological systems

Cancer News and Research

Latest Cancer News and Research

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Building quality into drug development for safer, faster medicines

How Pulp Fixin Is Turning Paper into High-Performance Sustainable Labware

A new method to measure intracellular water in biological systems

Newsletters you may be interested in